Qube Research & Technologies LTD Allogene Therapeutics, Inc. Transaction History

Qube Research & Technologies LTD

  • $65.7 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 13, 2024
BUY
$2.28 - $3.5 $1.34 Million - $2.05 Million
585,706 New
585,706 $1.88 Million
Q1 2023

May 15, 2023
SELL
$4.92 - $8.21 $255,018 - $425,548
-51,833 Reduced 27.71%
135,244 $668,000
Q4 2022

Feb 14, 2023
BUY
$5.62 - $11.11 $393,512 - $777,922
70,020 Added 59.82%
187,077 $1.18 Million
Q3 2022

Nov 14, 2022
BUY
$10.32 - $17.28 $1.21 Million - $2.02 Million
117,057 New
117,057 $1.26 Million

Others Institutions Holding ALLO

# of Institutions
163
Shares Held
134M
Call Options Held
59.4K
Put Options Held
113K
View Full List

About Allogene Therapeutics, Inc.

ALLO Quotes by TradingView
  • Ticker ALLO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 143,807,008
  • Market Cap $233M
  • Description
  • Allogene Therapeutics, Inc., a clinical stage immuno-oncology company, develops and commercializes genetically engineered allogeneic T cell therapies for the treatment of cancer. It develops, manufactures, and commercializes UCART19, an allogeneic chimeric antigen receptor (CAR) T cell product candidate for the treatment of pediatric and adult p...
More about ALLO
Track This Portfolio

Track Qube Research & Technologies LTD Portfolio

Follow Qube Research & Technologies LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

News

Stay updated on Qube Research & Technologies LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email